Loading…
This event has ended. View the official site or create your own event → Check it out
This event has ended. Create your own
View analytic
Wednesday, June 21 • 2:00pm - 3:15pm
#356: Value-Based Conversations with Payers: Issues, Opportunities, and Barriers

Sign up or log in to save this to your schedule and see who's attending!

Component Type: Session
Level: Intermediate
CE: CME 1.25; IACET 1.25; RN 1.25

This session will review the drivers for value-based contracting including risk taking by providers and payers, and the barriers. These barriers include FDA labeling decisions, communication of unapproved uses, Medicaid best price and anti-kickback concerns.

Learning Objectives

Describe the business, regulatory, and legal considerations surrounding value-based contracting conversations with payers.

Chair

Richard Gliklich, MD

Speaker

Aligning Stakeholder Needs for Value-Based Contracts
Richard Gliklich, MD

Manufacturer Perspective
Robert Duffield, II, JD

Payer Perspective
Jim Clement, MHA



Moderators
avatar for Richard Gliklich

Richard Gliklich

Chief Executive Officer, OM1
Dr. Richard Gliklich is the CEO of OM1, Inc., a company focused on outcomes measurement and personalization of big data for health care. Previously, he was founder and CEO of Outcome, which he led from inception through its acquisition by Quintiles. A graduate of Yale University... Read More →

Speakers
JC

Jim Clement

Executive Director, Cost of Care and Supply Chain Strategy, Aetna, Inc.
Mr. Clement is the Executive Director for Aetna Pharmacy Management and is responsible for transforming the financing of the pharmacy benefit. Jim maintains administrative oversight for PBM strategy, actuarial services, client pricing, and analytics. Prior to Aetna, Mr. Clement w... Read More →
avatar for Robert Duffield

Robert Duffield

Counsel, Novo Nordisk A/S
Robert P. Duffield, II is currently Counsel for Market Access at Novo Nordisk based in Plainsboro, NJ. He advises on a variety of matters impacting the global pharmaceutical industry, but focuses primarily on managed markets issues including contracting strategy. He supports Novo... Read More →
avatar for Richard Gliklich

Richard Gliklich

Chief Executive Officer, OM1
Dr. Richard Gliklich is the CEO of OM1, Inc., a company focused on outcomes measurement and personalization of big data for health care. Previously, he was founder and CEO of Outcome, which he led from inception through its acquisition by Quintiles. A graduate of Yale University... Read More →


Wednesday June 21, 2017 2:00pm - 3:15pm
S503ab McCormick Place 2301 South Martin Luther King Jr. Drive, Gate 4 Chicago, IL 60616